Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $451,943.58 in Stock
MarketBeat
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CFO Adam Scott Levy sold 10,758 shares of the stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $42.01, for a total transaction of $451,943.58. Following the sale, the chief financial officer directly owned 116,865 shares of the company's stock, valued at $4,909,498.65. The trade was a 8.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
NASDAQ:MLYS